9/22/20 - Leaderboard - Pharma

Bivalirudin reduces the risk of blood clotting in adults with unstable angina pectoris, who are undergoing percutaneous coronary intervention (PCI) or a procedure to open blocked arteries in the heart.

Rate and Review PolyPeptide Laboratories

Rating: 0 - 0 reviews
Let users know what you would have wanted to know about this company.
Click on a star to rate this company
 
  Privacy Policy.
When writing a review, please adhere to the Review Guidelines.